Charles Sternberg, Associate Editor06.23.22
BBS Automation has acquired Kahle Automation S.r.l., an Italian supplier of high-speed automation equipment for the MedTech and Life Sciences industries, catering to a wide spectrum of medical applications.
Through the acquisition of Kahle, BBS continues to execute on its dedicated MedTech/Life Sciences growth strategy. The Lombardy-based company adds proprietary technology and extensive know-how to BBS’ technology portfolio and will become the new global hub for BBS’ MedTech/Life Sciences activities.
The acquisition complements BBS’ existing hubs in Chicago (US) and Kunshan (China) and accelerates BBS’ journey to become a diversified global automation leader also in the MedTech/Life Sciences segment.
Kahle is owner-led by CEO Federico Ceresetti and president Julie Logothetis and has a long track record of profitable growth. It caters primarily to the market segments of syringes & needles, liquid dispensing, catheters and diagnostic devices, where it has built market leading expertise and long-lasting customer relationships. The company engages around ~110 people, with whom they serve customers in both Europe and overseas.
Kahle marks BBS’ fourth add-on under EQT ownership and follows the acquisition of ANT Solutions, a Polish provider of digital factory solutions in November 2018, TEAM (now BBS Winding), a founder-led Italian specialist for winding technology for electric motors in May 2019, and ReaLead (now BBS Kunshan), an automation solutions provider catering to a diverse range of automation solutions including die casting parts, electric vehicle parts and the 5G telecommunication space, in October 2019.
Kahle will continue to be led by its management team around CEO Federico Ceresetti and retain its branding, operating under the name “Kahle – a BBS Company”. The transaction is subject to regulatory approval. Financial terms of the transaction were not disclosed.
Through the acquisition of Kahle, BBS continues to execute on its dedicated MedTech/Life Sciences growth strategy. The Lombardy-based company adds proprietary technology and extensive know-how to BBS’ technology portfolio and will become the new global hub for BBS’ MedTech/Life Sciences activities.
The acquisition complements BBS’ existing hubs in Chicago (US) and Kunshan (China) and accelerates BBS’ journey to become a diversified global automation leader also in the MedTech/Life Sciences segment.
Kahle is owner-led by CEO Federico Ceresetti and president Julie Logothetis and has a long track record of profitable growth. It caters primarily to the market segments of syringes & needles, liquid dispensing, catheters and diagnostic devices, where it has built market leading expertise and long-lasting customer relationships. The company engages around ~110 people, with whom they serve customers in both Europe and overseas.
Kahle marks BBS’ fourth add-on under EQT ownership and follows the acquisition of ANT Solutions, a Polish provider of digital factory solutions in November 2018, TEAM (now BBS Winding), a founder-led Italian specialist for winding technology for electric motors in May 2019, and ReaLead (now BBS Kunshan), an automation solutions provider catering to a diverse range of automation solutions including die casting parts, electric vehicle parts and the 5G telecommunication space, in October 2019.
Kahle will continue to be led by its management team around CEO Federico Ceresetti and retain its branding, operating under the name “Kahle – a BBS Company”. The transaction is subject to regulatory approval. Financial terms of the transaction were not disclosed.